Skip to content
POM-V Prescription Required Companion Animal

Veraflox 25 mg/ml Oral Suspension for Cats

Active ingredient: Pradofloxacin

Form

Tablet

Species

Cats

Manufacturer

Elanco Animal Health GmbH

VMD MA No.

04895/5010

What it's used for

•Staphylococcus intermedius group (including S. pseudintermedius

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Pradofloxacin

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Veraflox 25 mg/ml Oral Suspension for Cats — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

•Staphylococcus
intermedius group (including S. pseudintermedius
The recommended dose is 5 mg/kg bodyweight of pradofloxacin once daily. To
ensure a correct dosage, body weight should be determined as accurately as
possible. Due to the graduation of the syringe the resulting dose range is 5 to 7.5
mg/kg bodyweight according to the following table:
Bodyweight
(kg)
Dose of oral suspension to
be given (ml)
> 0.67 - 10.2>1 – 1.50.3>1.5 – 20.4>2 – 2.50.5>2.5 – 30.6>3 – 3.50.7>3.5 – 40.8>4 – 51>5 – 61.2>6 – 71.4>7 – 81.6>8 – 91.8>9 – 102

Amended pages: December 2025
Duration of treatment
The duration of the treatment depends on the nature and severity of the infection and
on the response to treatment. For most infections the following treatment courses will
be sufficient:
IndicationDuration of treatment
(days)
Wound infections and abscesses7Acute infections of the upper respiratory
tract
The treatment should be reconsidered if no improvement of the clinical condition is
observed within 3 days after starting the treatment.
Method of administration
To facilitate accurate dosing, the 15 ml bottle of Veraflox oral suspension is supplied
with a 3 ml oral dosing syringe (graduation: 0.1 to 2 ml).

Shake well before
use.
Draw out the
equivalent dosage into
the syringe.
Administer directly
into the mouth.
To avoid cross-contamination, the same syringe should not be used for different
animals. Thus, one syringe should only be used for one animal. After administration,
the syringe should be cleaned with tap water and stored in the carton box together
with the veterinary medicinal product.
Do not use in cases of hypersensitivity to the active substance or to any of the
excipients.
Do not use in kittens aged less than 6 weeks.
Pradofloxacin has no effects on the developing cartilage of kittens of 6 weeks of age
and older. Do not use in cats with persisting articular cartilage lesions, since lesions
may worsen during treatment with fluoroquinolones.
Do not use in cats with central nervous system (CNS) disorders, such as epilepsy,
as fluoroquinolones could potentially cause seizures in predisposed animals.
Do not use in cats during pregnancy and lactation (see section 3.7).
Cats.
Rare
(1 to 10 animals / 10,000 animals
treated):
Digestive tract disorder (e.g. Vomiting)
1
Mild and transient
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian,
to either the marketing authorisation holder or the national competent authority via
the national reporting system. See the package leaflet for respective contact details.
Cross-resistance has been shown between pradofloxacin and other
fluoroquinolones. Use of pradofloxacin should be carefully considered when
susceptibility testing has shown resistance to fluoroquinolones because its
effectiveness may be reduced.

Special precautions for safe use in the target species:
Use of the product should be based on identification and susceptibility testing of the
target pathogen(s). If this is not possible, therapy should be based on
epidemiological information and knowledge of susceptibility of the target pathogens
at local/regional level..
Use of the product should be in accordance with official, national and regional
antimicrobial policies.
An antibiotic with a lower risk of antimicrobial resistance selection (lower AMEG
category) should be used for first line treatment where susceptibility testing suggests
the likely efficacy of this approach. Narrow spectrum antibiotic therapy with a lower
risk of antimicrobial resistance selection should be used for first line treatment where
susceptibility testing suggests the likely efficacy of this approach.
Pradofloxacin may increase sensitivity of the skin to sunlight. During treatment,
animals should therefore not be exposed to excessive sunlight.

Amended pages: December 2025
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
People with known hypersensitivity to quinolones should avoid any contact with the
veterinary medicinal product.
Avoid skin and eye contact with the veterinary medicinal product. Wash hands after
use.
In case of accidental contact with the eyes, wash immediately with water.
In case of contact with the skin, rinse off with water.
Do not eat, drink or smoke while handling the veterinary medicinal product
In case of accidental ingestion, seek medical advice and show the package leaflet or
the label to the physician.
Special precautions for the protection of the environment:
Not applicable.
Concurrent administration with metal cations such as those contained in antacids or
sucralfate made with magnesium hydroxide or aluminium hydroxide, or multivitamins
containing iron or zinc, and dairy products containing calcium, has been reported to
decrease the bioavailability of fluoroquinolones. Therefore, the veterinary medicinal
product should not be administered concurrently with antacids, sucralfate,
multivitamins or dairy products, as absorption of the veterinary medicinal product
may be decreased.
Further, fluoroquinolones should not be used in combination with non-steroidal anti-
inflammatory drugs (NSAIDs) in animals with a history of seizures because of
potential pharmacodynamic interactions in the CNS. The combination of
fluoroquinolones with theophylline could increase the plasma levels of theophylline
by altering its metabolism and thus should be avoided. The combined use of
fluoroquinolones with digoxin should also be avoided because of potentially
increased oral bioavailability of digoxin.
Store in the original container.
Keep the bottle tightly closed.
Not applicable.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.